Cargando…
Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
Ferroptosis is a novel type of regulated cell death, whose unique metabolic characteristics are commonly used to evaluate the conditions of various diseases especially in tumors. Accumulating evidence supports that ferroptosis can regulate tumor development, metastasis, and therapeutic responses. Co...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163417/ https://www.ncbi.nlm.nih.gov/pubmed/35668934 http://dx.doi.org/10.3389/fphar.2022.879317 |
_version_ | 1784719916415320064 |
---|---|
author | Nie, Zhenyu Chen, Mei Gao, Yuanhui Huang, Denggao Cao, Hui Peng, Yanling Guo, Na Wang, Fei Zhang, Shufang |
author_facet | Nie, Zhenyu Chen, Mei Gao, Yuanhui Huang, Denggao Cao, Hui Peng, Yanling Guo, Na Wang, Fei Zhang, Shufang |
author_sort | Nie, Zhenyu |
collection | PubMed |
description | Ferroptosis is a novel type of regulated cell death, whose unique metabolic characteristics are commonly used to evaluate the conditions of various diseases especially in tumors. Accumulating evidence supports that ferroptosis can regulate tumor development, metastasis, and therapeutic responses. Considering to the important role of chemotherapy in tumor treatment, drug resistance has become the most serious challenge. Revealing the molecular mechanism of ferroptosis is expected to solve tumor drug resistance and find new therapies to treat cancers. In this review, we discuss the relationship between ferroptosis and tumor drug resistance, summarize the abnormal ferroptosis in tissues of different cancer types and current research progress and challenges in overcoming treatment resistance, and explore the concept of targeting ferroptosis to improve tumor treatment outcomes. |
format | Online Article Text |
id | pubmed-9163417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91634172022-06-05 Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges Nie, Zhenyu Chen, Mei Gao, Yuanhui Huang, Denggao Cao, Hui Peng, Yanling Guo, Na Wang, Fei Zhang, Shufang Front Pharmacol Pharmacology Ferroptosis is a novel type of regulated cell death, whose unique metabolic characteristics are commonly used to evaluate the conditions of various diseases especially in tumors. Accumulating evidence supports that ferroptosis can regulate tumor development, metastasis, and therapeutic responses. Considering to the important role of chemotherapy in tumor treatment, drug resistance has become the most serious challenge. Revealing the molecular mechanism of ferroptosis is expected to solve tumor drug resistance and find new therapies to treat cancers. In this review, we discuss the relationship between ferroptosis and tumor drug resistance, summarize the abnormal ferroptosis in tissues of different cancer types and current research progress and challenges in overcoming treatment resistance, and explore the concept of targeting ferroptosis to improve tumor treatment outcomes. Frontiers Media S.A. 2022-05-20 /pmc/articles/PMC9163417/ /pubmed/35668934 http://dx.doi.org/10.3389/fphar.2022.879317 Text en Copyright © 2022 Nie, Chen, Gao, Huang, Cao, Peng, Guo, Wang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Nie, Zhenyu Chen, Mei Gao, Yuanhui Huang, Denggao Cao, Hui Peng, Yanling Guo, Na Wang, Fei Zhang, Shufang Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges |
title | Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges |
title_full | Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges |
title_fullStr | Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges |
title_full_unstemmed | Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges |
title_short | Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges |
title_sort | ferroptosis and tumor drug resistance: current status and major challenges |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163417/ https://www.ncbi.nlm.nih.gov/pubmed/35668934 http://dx.doi.org/10.3389/fphar.2022.879317 |
work_keys_str_mv | AT niezhenyu ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT chenmei ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT gaoyuanhui ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT huangdenggao ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT caohui ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT pengyanling ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT guona ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT wangfei ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges AT zhangshufang ferroptosisandtumordrugresistancecurrentstatusandmajorchallenges |